Medicare Enrolled
Dr. John Migas, M.D.
Medical Oncology · Normal, IL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Migas from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Migas?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Migas
Dr. John Migas is a medical oncology specialist in Normal, IL, with 21 years of NPI registration. Based on federal Medicare data, Dr. Migas performed 7,659 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Migas received a total of $3,737 from 20 pharmaceutical and/or device companies across 51 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Migas is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 21 years of NPI registration
▲ Top 19% volume in IL
$3,737 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗7,659
Medicare services
Top 19% in IL for medical oncology
Not available
Unique patients (not deduplicated)
$15
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,670 | $0 | $1 |
| Anti-nausea injection (Aloxi/palonosetron) | 990 | $1 | $35 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
863 | $8 | $20 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
843 | $8 | $45 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
591 | $59 | $175 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
420 | $10 | $55 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
363 | $12 | $140 |
| Liver function blood test panel | 253 | $8 | $52 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
202 | $94 | $250 |
| Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 | 198 | $20 | $60 |
| Lactate dehydrogenase (LDH) level test A blood test that measures the amount of lactate dehydrogenase, an enzyme found in many body tissues. It helps assess tissue damage or disease. |
181 | $6 | $30 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
149 | $97 | $443 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
148 | $21 | $190 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
107 | $10 | $80 |
| Iron level test | 69 | $6 | $40 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
68 | $13 | $50 |
| Reticulated platelet measurement A blood test that measures the level of young, newly formed platelets in the body. |
64 | $35 | $59 |
| Direct bilirubin level test A blood test that measures the amount of direct bilirubin in your body. Direct bilirubin is the form of the waste product processed by the liver. |
58 | $5 | $30 |
| Immunoglobulin level test A blood test that measures the level of gammaglobulins, which are immune system proteins. |
53 | $9 | $30 |
| Magnesium level test A blood test to measure the amount of magnesium in your body. This helps check for magnesium deficiency or excess. |
51 | $7 | $25 |
| Iron binding capacity test A blood test that measures the amount of iron in the blood and the blood's ability to bind and transport iron. |
48 | $9 | $40 |
| Thyroid stimulating hormone (TSH) test A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function. |
48 | $16 | $60 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
46 | $47 | $240 |
| Free thyroxine (T4) test A blood test that measures the level of free thyroxine, a thyroid hormone, in the bloodstream. |
37 | $9 | $30 |
| Carcinoembryonic antigen (CEA) level test A blood test that measures the level of carcinoembryonic antigen (CEA) protein. This test is used to monitor certain types of cancer. |
29 | $19 | $55 |
| Manual white blood cell count A laboratory test that involves examining a sample under a microscope to manually count the number of white blood cells present. |
27 | $4 | $30 |
| Complete blood count (CBC), automated An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood. |
27 | $6 | $25 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
25 | $121 | $410 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
19 | $79 | $260 |
| Vitamin D level test A blood test to measure the amount of Vitamin D-3 in your body. |
12 | $29 | $60 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
2.5% high complexity
42.8% medium
54.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$3,737
Total received (2018-2024)
Avg $534/year across 7 years
Top 46% in IL for medical oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
20
Companies
51
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$143
2023
$261
2022
$218
2021
$156
2020
$63
2019
$1,623
2018
$1,272
Payments by company (2024)
Astellas Pharma US Inc
$60
PFIZER INC.
$32
Eisai Inc.
$28
ABBVIE INC.
$24
Top 3 companies account for 83.6% of 2024 payments
All-time payments by company (2018-2024) ›
PFIZER INC.
$3,000
Janssen Biotech, Inc.
$149
Genentech USA, Inc.
$84
Astellas Pharma US Inc
$60
Novartis Pharmaceuticals Corporation
$60
Celgene Corporation
$46
GENZYME CORPORATION
$42
TAIHO ONCOLOGY, INC.
$35
E.R. Squibb & Sons, L.L.C.
$33
Amgen Inc.
$29
Eisai Inc.
$28
AbbVie Inc.
$27
ABBVIE INC.
$24
Seagen Inc.
$23
ADC Therapeutics America, Inc.
$20
EISAI INC.
$18
AstraZeneca Pharmaceuticals LP
$18
GlaxoSmithKline, LLC.
$17
ARRAY BIOPHARMA INC
$12
Gilead Sciences, Inc.
$12
Top 3 companies account for 86.5% of all-time payments
Associated products mentioned in payments ›
Alecensa · BRAFTOVI · ELIQUIS · ENHERTU · EPKINLY · ERLEADA · GAZYVA · IBRANCE · INLYTA · JEVTANA · LIBTAYO · LONSURF · LUMAKRAS · LUTATHERA · Lenvima · OJJAARA · OPDIVO · PADCEV · PROMACTA · Pomalyst · REBLOZYL · SUTENT · TASIGNA · VENCLEXTA · Vyloy · XTANDI · Xospata
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Medical oncologists in nearby ZIP areas
1
County median income
$78,329
Nearest hospital to ZIP centroid (approximate)
CARLE BROMENN MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Migas is a mixed practice specialist, with above-average Medicare volume (top 19% in IL), with 21 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Migas experienced with dexamethasone injection (steroid)?
Based on Medicare claims data, Dr. Migas performed 1,670 dexamethasone injection (steroid) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Migas receive payments from pharmaceutical companies?
Yes. Dr. Migas received a total of $3,737 from 20 companies across 51 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Migas's costs compare to other medical oncologists in Normal?
Dr. Migas's average Medicare payment per service is $15. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Migas) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Medical Oncologists in Normal
Browse medical oncologists in Normal ranked by procedure volume and transparency data.
Highest volume
Top Medical Oncologists in IL
Medical oncologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Medical Oncologists in IL
Which IL medical oncologists receive the most from drug and device companies.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
Genentech USA, Inc. Payments to Doctors
See all physicians who received payments from Genentech USA, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology